Market Research Blog

In 2022, the focused ultrasound system market was estimated to be worth $7 billion. Additionally, the total demand for focused ultrasound systems is anticipated to grow at a strong CAGR of 6.1% between 2022 and 2032, reaching a total of approximately US$ 9.2 Bn by 2032, due to the rising prevalence of various chronic and infectious diseases as well as the growing preference for non-invasive treatment methods.

Focused ultrasound is image guided, non-invasive surgical procedure used for the treatment of brain and various other body parts by targeting the tissues with ultrasonic energy. Various conditions such as Alzheimer’s, uterine fibroids and essential tremor, etc.

Download Sample Copy@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8582

The focused ultrasound system is generally used for the tissues which are deep inside the body. The non-invasive nature of the focused ultrasound system to treat various conditions is the vital point of traction in the current as well as future prospect of focused ultrasound system market growth.

Various manufacturers are investing heavily in the research and development for the focused ultrasound system. For example, INSIGHTEC Ltd. Israel based medical device company currently developing a first of it’s kind focused ultrasound system for treatment of Parkinson’s disease and it is in stage three of clinical trials for the FDA approval.

Focused Ultrasound System Market: Drivers and Restraints

Focused ultrasound system market is majorly driven by the non-invasive and site specific nature of the treatment of various diseases without affecting the surrounding tissues. The treatment with focused ultrasound system requires around 2 to 4 hours only without need of analgesia which in turn further increases patient compliance and ease of treatment procedure fueling the growth of the market.

The reduced time or no time of inpatient stay after treatment with focused ultrasound system further decreases the economic burden of treatment and increasing traction of market growth. By coupling the ultrasound with MRI scanner healthcare professionals can actually see the real time visuals of tissues to be treated hence improving preciseness as well as therapeutic outcome.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-question/rep-gb-8582

Increasing number of clinical trials and increasing spending on research and development by the focused ultrasound system manufacturing companies further expected to drive the growth of focused ultrasound system market. The performance evaluation of the focused ultrasound system for treatment of different diseases further expected to drive the growth of focused ultrasound system market in near future.

Whereas, low product penetration in the middle and low income countries may hamper the potential growth prospect of the focused ultrasound system market.

Focused Ultrasound System Market: Overview

The global focused ultrasound system market is majorly driven by the increasing patient compliance with the non-invasive treatment procedures. By technology, focused ultrasound system market is expected to be dominated by the MR-guided focused ultrasound system segment due to high efficiency as compared to other.

By application, focused ultrasound system market is expected to be dominated by the oncology segment due to high number of procedures. By end user, focused ultrasound system market is expected to be dominated by the hospital segment due to high patient footfall for the treatment.

Request for Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-8582

Focused Ultrasound System Market: Regional Outlook

The global market is expected to be North America due to high product penetration and high number of procedures. Europe is expected to be second most lucrative focused ultrasound system market due to higher patient preference for non-invasive treatment.

Latin America focused ultrasound system market is expected to experience steady growth due to increasing number of procedures using focused ultrasound system. Asia-Pacific is expected to be the fastest growing focused ultrasound system market due to rapidly improving healthcare infrastructure in the countries such as India and China.

Middle East and Africa is expected to be the least lucrative focused ultrasound system market due to low product penetration and lack of proper healthcare infrastructure in majority of the region.

Focused Ultrasound System Market: Key Players

The key players operating in the global market are: ALPINION MEDICAL SYSTEMS Co., Ltd., INSIGHTEC Ltd., Sonacare Medical, GENERAL ELECTRIC COMPANY, Siemens Ltd., Haifu Medical Technology Co., Ltd., FUS Instruments, MEDSONIC LTD, Mirabilis Medical, Inc., EDAP, and others

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Key Segments Profiled in the Focused Ultrasound Systems Market Survey

By Technology:

• Ultrasound-Guided
• MR-Guided

By Application:

• Oncology
• Neurosurgery
• Urology
• Cosmetics
• Other

By End User:

• Hospitals
• Laboratories
• Specialty Clinics

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Top Related Reports Healthcare Market Insights

 https://loop.joshwho.net/posts/28328577?utm_source=manual

https://www.xaphyr.com/blogs/164253/Sleep-Apnea-Devices-Market-Research-Segmentation-Key-Players-Analysis-Forecast

https://www.fdboo.com/read-blog/13398

https://app.socie.com.br/read-blog/6461

https://www.shtfsocial.com/blogs/21491/Sleep-Apnea-Devices-Market-To-Undertake-Strapping-Growth-By-The

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The global sleep apnea devices market growth is anticipated to grow at a CAGR of 7.8% over the forecast period, up from US$ 7 Bn in 2021 to US$ 9.5 billion by 2026.

The expanding prevalence of sleep apnea and related co-morbidities and expanding knowledge about sleep disorders are among the primary drivers driving overall sleep apnea devices market expansion.

Technological improvement is expected to boost the sleep apnea devices market growth during the forecast period. These improvements in oral appliances, oxygen devices, and actigraphy systems have improved sleep disorders’ treatment results and success rate.

Players in the sleep apnea devices market are concentrating their efforts on research and development in order to create novel technology.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14383

Newly released lightweight, portable sleep apnea solutions are integrated with pressure compensating sensors that can correct for altitude-related reductions in atmospheric pressure, enhancing their acceptance. Sleep apnea devices are becoming increasingly popular since they provide patients with more options and freedom.

Thus, the adoption of technology-enabled sleep apnea devices for both diagnostic and therapeutic reasons in various sleep disorders is expected to skyrocket in the future years.

One of the key challenges impeding the adoption of sleep apnea devices is a lack of commitment to sleep apnea therapy. Positive airway pressure sleep apnea devices are highly recommended for treating a variety of sleep disorders. Despite their great effectiveness, these devices’ action efficacy is limited in certain circumstances due to the fact that they require correct and frequent usage as well as ongoing medical monitoring.

In the medium term, this lack of adherence will be a key impediment to the expansion of the sleep apnea equipment market. However, in the long run, it will have little influence because sleep apnea devices manufacturers are focusing on making their sleep apnea devices more technologically sophisticated and lowering the difficulties associated with their adherence to sleep apnea therapy.

The increased incidence of sleep disorders and related co-morbidities is predicted to considerably enhance sleep apnea devices market revenue.

The rapidly rising senior population suffering from sleep apnea and related health concerns have accelerated the need for sleep disorders diagnosis and treatment, which has favourably impacted the sleep apnea devices market revenue.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14383

Key Takeaways:

• By type, therapeutic devices account for the majority of the market for sleep apnea devices owing to the increasing adoption of sleep apnea therapeutic devices and improving reimbursement scenarios for these devices.
• By end use, the home care settings segment is expected to grow at the fastest CAGR due to increasing patient and insurance company preference for home sleep testing, as well as a favourable reimbursement scenario for home sleep testing.
• Due to the rising prevalence of elderly people with chronic diseases such as diabetes and obesity, the geriatric segment is expected to dominate the sleep apnea devices market, thereby spiking the sales of sleep apnea devices.
• The direct tender segment is expected to dominate the global sleep apnea devices market since it provides high-quality and easily accessible sleep apnea devices to hospitals, diagnostic centers, ambulatory care centers, and specialty care centers.
• During the forecast period, Asia Pacific is expected to advance at a rapid pace and experience huge demand for sleep apnea devices on account rising elderly population and an increase in the prevalence of lifestyle illnesses.

“North America is projected to be at the forefront of the sleep apnea devices market due to the prevalence of expanding technological advancement in the region and major market players. On account of rising healthcare costs and well-established healthcare infrastructure, the obstructive sleep apnea syndrome segment in the United States of North America is expected to hold a large sleep apnea devices market share.” says an FMI analyst.

Competitive Landscape:

The major sleep apnea devices market companies providing sleep apnea devices are:

• ResMed
• Itamar Medical Ltd.
• Natus Medical Incorporated
• CONTEC MEDICAL SYSTEMS CO., LTD
• Koninklijke Philips N.V.
• BMC Medical Co., Ltd.
• SomnoMed, Medicom MTD Ltd
• Somnowell
• Fisher & Paykel Healthcare Limited

Many product launches and agreements are also being initiated by companies around the world, which is accelerating the sleep apnea devices market opportunities.

Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-14383

Key Segments

By Product

• Therapeutics

Airway Clearance Systems

Adaptive Servo-ventilation (ASV)

Positive Airway Pressure (PAP) Device

Oral Appliances

Oxygen Devices

Others

• Diagnostics

Actigraphy Systems

Polysomnography (PSG) Device

Respiratory Polygraph

Sleep Screening Devices

By End User

Home Care Settings & Individuals

Sleep Laboratories & Hospitals

Top Related Reports Healthcare Market Insights

https://bookmarksmywebs.com/sleep-apnea-devices-market-segmentation-application-technology-analysis-research-report-to-2032/

https://healthcarefmi.blogspot.com/2022/10/sleep-apnea-devices-market-potential.html

https://healthandfitness901316.blogspot.com/2022/10/sleep-apnea-devices-market-creating.html

https://myjoye.com/blogs/773/3442/sleep-apnea-devices-market-report-overview-with-geographical-s

https://justnock.com/read-blog/12155

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 5-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

As per Future Market Insights, the global optical coherence tomography market was valued at over US$ 1.1 Bn in 2021, and is expected to exhibit a CAGR of 9.8% over the forecast period (2022-2032).

Optical coherence tomography systems include widespread applications within the medical, technical and non-medical sectors. With increasing applications, key manufacturers are focusing on innovations to persevere the novel application specifications of their products, thus maintaining a robust portfolio.

Download Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-3362

Incorporation of automated technology for early disease indication is providing a boost to the development of smart engineered devices. This is set to enhance the overall market value of optical coherence tomography systems.

FMI opines, high cost of equipment establishment and maintenance, as well as the requirement of skilled professionals for operating such systems will act as a restraint to the overall growth of the market.

However, rising research activities on improving various device features to encompass a range of device applications along with the grant of pre-market approvals for such devices and systems is set to promote the sales of OCT systems globally.

Key Takeaways from Market Study

• Based on product type, fourier domain optical coherence tomography (FD-OCT) systems are expected to hold over 66.6% market value share by the end of 2032.
• Clinical applications held a market share value of 63.4% in 2021 owing to growing rate of eye disease and need for advanced clinical set up for patients.
• In terms of scanning speed, the 32000 A-scans/sec segment held maximum market share value of 15.6% in 2021.
• Healthcare settings held a market share value of 62.7%in 2021 and the trend is likely to continue in the future owing to the growing patient pool within the healthcare settings
• North America is slated to be the largest leading region with a value share of 44.2% at the end of the forecast period.“Wide applications of OCT systems within the medical sphere has encouraged the adoption of optical coherence tomography systems over the globe” says an analyst of Future Market Insights.

Contact our Market Research Specialist: https://www.futuremarketinsights.com/ask-question/rep-gb-3362

Market Competition

Key companies are rapidly advancing towards the design and development of OCT systems which will promote larger precision and lower time-related analysis of disease during, thus determining accuracy with swift metrics on patient health.

• In November 2020, NIDEK Co. Ltd. launched a Mirante SLO model with advanced functionality and imaging capabilities.
• In June 2021, Excelitas Technologies announced the acquisition of PCO AG to expand its portfolio of sensing, illumination, and optical products.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the optical coherence tomography market in its latest study, presenting historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product (time-domain (TD-OCT) systems and Fourier domain optical coherence tomography (FD-OCT) Systems (spectral domain-OCT and swept source-OCT)), application (clinical(ophthalmology, cardiovascular, dermatology and dental) and industrial (non-destructive testing, industrial quality control and others)), scanning speed (400 A-scans/sec, 4000 A-scans/sec, 20000 A-scans/sec, 32000 A-scans/sec, 40000 A-scans/sec, 70000 A-scans/sec, 80000 A-scans/sec, 100000 A-scans/sec and 250,000 A-scans/sec), end user (healthcare settings (hospitals, ambulatory surgical centres and specialty clinics), food industry, semiconductor industries, chemical & polymer industries and automotive industry) and across seven key regions of the world.

Request Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-3362

Key Market Segments Covered in Optical Coherence Tomography Industry Research

By Product:

• Time-Domain Optical Coherence Tomography (TD-OCT) Systems
• Fourier Domain Optical Coherence Tomography (FDOCT) Systems
  • Spectral Domain-OCT
  • Swept Source-OCT

By Application:

• Clinical
  • Ophthalmology
  • Cardiovascular
  • Dermatology
  • Dental
• Industrial
  • Non-destructive Testing
  • Industrial Quality Control
  • Others

By Scanning Speed:

• 400 A-scans/sec
• 4000 A-scans/sec
• 20000 A-scans/sec
• 32000 A-scans/sec
• 40000 A-scans/sec
• 70000 A-scans/sec
• 80000 A-scans/sec
• 100000 A-scans/sec
• 250,000 A-scans/sec

By End User:

• Healthcare Settings
  • Hospitals
  • Ambulatory Surgical Centres
  • Specialty Clinics
• Food Industry
• Semiconductor Industries
• Chemical & Polymer Industries
• Automotive Industry

Top Trending Reports Healthcare Market Insights

https://london-news-community.tribeplatform.com/general/post/sleep-apnea-devices-market-regional-outlook-trends-key-companies-GE7cRgsvz0hZoVg

https://club.vexanium.com/post/the-global-sleep-apnea-devices-market-size-is-anticipated-to-grow-at-a-cagr–6359161a613e59d2304f78dc

https://community.wongcw.com/blogs/220246/Sleep-Apnea-Devices-Market-Growth-Future-Prospects-And-Competitive-Analysis

https://wakelet.com/wake/VpfLZfwfBc0XSFt71L_hA

https://kaalama.org/read-blog/198256

About Future Market Insights (FMI)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

According to a recent market study by Future Market Insights (FMI), the global radial compression devices market is predicted to reach US$ 504.0 Mn by 2031, valued at US$ 232.5 Mn in 2022.

A radial compression device is a band that is placed around the wrist to lessen the risk of radial artery blockage following invasive cardiac operations. This device is used to stop bleeding following an angiography or angioplasty procedure.

In recent years, the global market for radial compression devices has greatly evolved. These have been strengthened by the development of technology that accelerate the time it takes to reach hemostasis, enhance the process, and lower the risk of radial artery occlusion (RAO). RAO concerns have been a major source of worry when accessing the transracial artery for cardiac catheterization, resulting in the development of the radial compression device market.

Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2401

“Growing number of percutaneous coronary intervention procedures (PCI), acceptance of compression devices for surgical and diagnostic cardiology interventions, new product launches and approvals – leading to greater availability in both established and emerging economies are factors driving the growth of radial compression devices market.”

Furthermore, the advantages of radial access in a percutaneous coronary intervention (PCI) procedure are expected to drive the market growth. Radial access allows patients to move more quickly, the incision is smaller, and the chances of infection at the site are much lower than with trans-femoral access.

Key Takeaways from Radial Compression Device Study:

• Band/Strap based products provides rigid wrist support, and improved patient comfort which leads the segment to account for the maximum share of 8% in 2021, expanding at 9.7% CAGR during the forecast period.
• Disposable devices accounted for 92.9% of the market share in 2021 indicating highest demand by usage segment due to ease in use and cost effective and being mainly used in gaining and maintaining the hemostasis of the radial.
• With the increasing diagnosis rather than surgical intervention the diagnostic intervention, by application held the largest share of 50.5% in 2021 and is expected to grow with the same trend by 2031.
• North America held the largest share of 40.5% of the global radial compression devices market in 2021 indicating the growth due to geriatric population and growing demand for advanced medical technology in North America.

Ask to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-2401

Who is winning?

The key market players covered by FMI include leading companies of radial compression devices are Terumo Corporation, Merit Medical Inc., Abbott Laboratories, Vascular Solution, Advanced Vascular Dynamics, Conmed B.V., Beijing Demax Medical Technology, Teleflex Incorporated, Forge Medical Inc., TZ Medical Inc., Semler Technologies, MedPlus Inc., Lepu Medical, Cardinal Health, and Vygon.

Some of the leading manufacturers in the radial compression devices market are working to develop their technologically advanced product in order to improve the efficacy and safety profile for patients. Interventional cardiologists and radiologists in the healthcare industry profit from continuous technological advancements made by few of these players. Furthermore, manufacturers are also focusing on mergers and acquisitions with global expansion objectives, thereby, enhancing their market presence.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global radial compression devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on radial compression devices segment based on Product (Band/Strap based radial compression devices, knob based radial compression devices, plate based radial compression devices), Usage (Reusable, disposable), Application (diagnostic intervention, surgical intervention), end user (hospitals, independent catheterization labs, ambulatory surgery centers, specialized centers) across seven major regions.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-2401

Radial compression devices Market by Category

By Product:

• Band/Strap based radial compression devices
• Knob based radial compression devices
• Plate based radial compression devices

By Usage:

• Disposable Devices
• Reusable Devices

By Application:

• Diagnostic intervention
• Surgical intervention

By End User:

• Hospitals
• Independent Catheterization Labs
• Ambulatory Surgery Centers
• Specialized Centers

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Top Related Reports Healthcare Market Insights

https://www.xing.com/discover/detail-activities/6720929620.3d9314

https://www.spoke.com/topics/sleep-apnea-devices-market-analysis-and-market-studies-to-2032-63591574f8b2e307f301d417

https://www.pressreader.com/article/6755871904324925

https://www.letsdiskuss.com/post/sleep-apnea-devices-market-future-scenario-key-insights-top-companies-2032

https://www.scoop.it/topic/automotive-by-vishal-58/p/4137285204/2022/10/26/sleep-apnea-devices-market-will-generate-booming-growth-opportunities-to-2032?&kind=crawled&fId=1081630

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

By the end of 2031, sales of global biopsy device market size are projected to reach US$ 3089.2 Mn. The market is anticipated to experience a CAGR of 5.2% during the forecast period.

Rising burden of diseases such as lung cancer, breast cancer, leukemia, and others across the globe is accelerating the growth of the market. According to the American Cancer Society, approximately 1.9 million new cases of cancer are likely to be diagnosed in the U.S., out of which 608,570 of patients are predicted to succumb in the year 2021.

Thus, the demand for effective diagnostic procedures will rise as patients and their families look for advanced healthcare solutions for the treatment of cancer.

Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1192

Increasing number of initiatives undertaken by governments and healthcare organizations concerning cancer diagnosis and treatment will facilitate the growth of the market. Driven by the rising healthcare expenditure and progressive research and development (R&D) activities, the market is projected to reach a valuation of US$ 3.08 Bn by the end of 2031.

As per FMI, North America is expected to lead the global biopsy device market. Supported by the rising prevalence of cancer in countries such as the U.S. and Canada, the region is estimated to account for around 34% of the market share in 2021.

“Rising discretionary funding for cancer research, growing government expenditure for upgrading healthcare infrastructure, and implementation of favorable reimbursement policies will collectively propel the growth of the global biopsy device market,” says the FMI analyst.

Key Takeaways from FMI’s Biopsy Devices Market Survey

• The U.S. is expected to lead the North America market, favored by the presence of favorable reimbursement scenarios in the country.
• Germany is anticipated to hold around 28% of the Europe market share, owing to the growing healthcare expenditure and extensive R&D activities.
• China is projected to account for the highest share in the Asia Pacific biopsy devices market, due to the high patient pool of cancer.
• Japan and South Korea is forecast to cumulatively account for nearly 8.4% of the global market share in 2021.
• Based on product type, the biopsy needles segment is predicated to create an absolute dollar ($) opportunity of US$ 30 million in 2021.

Contact our Market Research Specialist @ https://www.futuremarketinsights.com/ask-question/rep-gb-1192

Key Drivers

• Rising prevalence of fatal diseases such as breast cancer and leukemia is fueling demand for biopsy devices.
• Increasing consumer preference towards minimally invasive procedures is spurring sales of biopsy devices.
• Rapid technological advancements such as ultrasound-guided biopsies and 3D optical biopsies is driving the market.

Competitive Landscape

As per FMI, the global biopsy device market is highly fragmented and around 69% of the global share is contributed by Dickinson and Company, CR Bard, Becton, B. Braun, Argon Medical Inc., Melsungen AG, Hologic, Inc, Devicor Medical Products Inc. and Cook Medical.

Leading companies in the market are focusing to developing new products and gaining regulatory approvals. Some of the players are adopting expansion strategies such as collaboration, mergers, partnership, and acquisitions to maintain their lead in the landscape. For instance,

• In 2021 Biocept, Inc., a commercial-stage cancer diagnostics company, announced entering into collaboration with an American clinical laboratory, Quest Diagnostics to offer laboratory testing services to patients in Quest for its Target Selectortm NGS-based liquid biopsy targeted lung cancer panel.
• In October 2020, GE Healthcare, a subsidiary of American multinational conglomerate General Electric incorporated, announced launching its new Serena Bright biopsy technology in the U.S. It is particularly designed to offer advanced breast cancer diagnosis and treatment.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1192

Some of the prominent players operating in the biopsy device market profiled by FMI are:

• Argon Medical Devices, Inc.
• Braun Melsungen AG
• Becton Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical, Inc.
• Danaher Corporation
• Fujifilm Holdings Corp.
• Hologic, Inc.
• Medtronic plc.

Biopsy Device Market – Market Segmentation

By Product Type:

• Guidance System
  • Stereotactic X-Ray Guided Biopsy
  • Ultrasound Guided Biopsy
  • MRI Guided Biopsy
• Needles
  • Core Needles
  • Fine Aspiration Needles
• Guns
• Reagents and Kits
• Others (Brushes, Curettes and Punches etc.)

By Application:

• Medical Diagnosis
• Scientific Research

By End Use:

• Hospital
• Specialised Oncology Centres
• Diagnostic Centres
• Research Institutes

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario.

Top Trending Reports Healthcare Market Insights

https://bicycle.one/read-blog/4427

https://s30477750928.whotrades.com/blog/43944534629?nrac=1

https://medium.com/@vishal.tupkar/the-global-sleep-apnea-devices-market-size-is-anticipated-to-grow-at-a-cagr-of-7-8-4b2d46ca19f5

https://www.evernote.com/shard/s703/client/snv?noteGuid=5c0b23f0-16e3-2476-c0b5-2f68a317f277&noteKey=3dc35709f955cb99997e7f6baac59655&sn=https%3A%2F%2Fwww.evernote.com%2Fshard%2Fs703%2Fsh%2F5c0b23f0-16e3-2476-c0b5-2f68a317f277%2F3dc35709f955cb99997e7f6baac59655&title=Sleep%2BApnea%2BDevices%2BMarket%253A%2BOverview%252C%2BData%2BUpdates%252C%2BReports%2BAnalysis%2B%2526%2BForecast%2B%257C%2BFM I

https://www.tumblr.com/researchvishal/699171834013368320/sleep-apnea-devices-market-top-trends-and?source=share&_branch_match_id=1092693908979658921&_branch_referrer=H4sIAAAAAAAAAwXB0Q3DMAgFwIkwUr6ibkPMqxzFxgho5u%2FdqPL8MEu1%2Bq1rRut7cSAh0cd755DJOQEncYOQ4r07kpbEg6LaThUwTRJT3mrf4zQ3fc4%2FndG0MFsAAAA%3D

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

A new research study by Future Market Insights (FMI) pegs global cancer supportive care products market to reach USD 32 Bn by 2030. The report titled, ‘Cancer Supportive Care Products Market’ offers in-depth insights on the future market growth, laying out strategies and recommendations that stakeholders can benefit from.

High growth and unmet needs have attracted various new players to cancer supportive care products market. About 23% of compounds in the preclinical drug pipeline were in oncology in 2000, and the number increased to 38% in 2019.

This is increasing the market competition with regards to clinical-trial recruitment – for instance, the number of breast-cancer patients needed for active clinical trials is surpassing the yearly figure of diagnoses.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2550

Efforts to manage drug expenditure have channelized the focus towards cancer supportive care products, especially in developed regions, where value-based health-technology assessments (HTAs) are prevalent.

The cancer supportive care products market is characterized by rapidly growing and globalized standard of medical care. Case in point, in non-small-cell lung cancer, the number of approved therapies was estimated to rise from 14 in 2009 to 22 by 2019.

This, coupled with limited data during accelerated approvals, implies that manufacturers are working in close collaboration with payers to create value proposition of cancer supportive care products.

Key Takeaways of Cancer Supportive Care Products Market Study

• Incidences of cancer have surged by around 26% among geriatric demographics compared to 10% among the remaining population
• Adoption of cancer supportive care products to remain prominent in treating lung cancer
• Pharma companies to invest 30% of their spending in cancer R&D to launch novel drugs and therapies in marketplace
• Market in Asia Pacific (APAC) to experience meteoric growth through 2030

COVID-19 Impact on Cancer Supportive Care Products Market

The COVID 19 pandemic has touched every facet of human life including, healthcare delivery for chronic disorders.

As such, these patients are highly susceptible to getting infected from COVID-19 due to their compromised immunity, putting cancer specialists and patients in a dilemma.

Several healthcare facilities are deferring “elective” screenings, surgeries, and other methods that are considered not urgent or not immediately fatal.

Request for Customization: https://www.futuremarketinsights.com/customization-available/REP-GB-2550

Such important decisions are taken on a case-to-case basis to make sure patients diagnosed with cancer are protected from contracting the coronavirus as well as to ensure that healthcare facilities are equipped with resources necessary to treat cancer patients who do get affected by the virus.

The COVID-19 crisis has disturbed the treatment pathways and in-progress care, thus, resulting in temporary drop in demand for cancer supportive care products.

“In an effort to address the untapped sections of the society, several regulatory bodies are showing immediacy in granting approvals to certain cancer supportive care products. Case in point, the US Food and Drug Administration (FDA) has approved Pfizer’s Nyvepria to help prevent infections in patients undergoing myelosuppressive chemotherapy,” says the analyst at FMI.

Cancer Supportive Care Products Market – Competitive Intelligence

The cancer supportive care products market is highly competitive, with presence of several small- and medium-sized players. Manufacturers are leveraging innovation into their best practices in order to have proper capabilities in place and stay ahead in the fast-growing and competitive arena.

• Baxter International Inc. develops products under the business categories – Renal Care, Medication Delivery, and Pharmaceuticals. The company develops REGLAN Injection, which is a metoclopramide injection.
• Amgen Inc. makes and provides innovative human therapeutics – Neulasta, which is a PEGylated form of human granulocyte CSF.

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/REP-GB-2550  

Want more insights?

Future Market Insights, in its new study, provides compelling insights about the cancer supportive care products market that encloses industry analysis for 2015 – 2019 and opportunity assessment for 2020 – 2030.

The report offers unbiased assessment on cancer supportive care products market through four different categories – by drug class, by indication, distribution channel, and region.

The global cancer supportive care products market research study delivers insights of pricing by different life cycle analysis, product life cycle, major market trends and technologies that are being utilized in the development of cancer supportive care products and product adoption in various end-use sectors

Top Related Reports Healthcare Market Insights

http://redonion.social/read-blog/3745

https://www.bookmarkrocket.com/story/airway-management-devices-market-future-trends-industry-size-and-forecast-to-2028/?status=approved&submitted=1

https://yourarticles.co.uk/?p=453597&preview=true&_preview_nonce=eed8132142

https://tiptopface.com/read-blog/591

https://forum.leblogger.fr/post/the-airway-management-devices-market-share-is-anticipated-to-develop-from-a–6359107e7d7de5128bcb5762

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period (2016 – 2026).

Segmentation highlights

The global renal biomarker market is segmented on the basis of Biomarker Type (Functional Biomarker, Up-Regulated Proteins, Others); Diagnostic Technique (Enzyme Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay, Colorimetric Assay, Chemiluminescent Enzyme Immunoassay, Liquid Chromatography-Mass Spectrometry); and End User (Diagnostic Labs,Outpatient Clinics, Research Centres, Hospitals).

Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1731

• The Functional Biomarker type segment is anticipated to be valued at US$ 471.2 Mn by the end of 2016, registering a CAGR of 7.6% over the forecast period. The Up-Regulated Proteins type segment is estimated to create absolute $ opportunity of US$ 19.5 Mn in 2017 over 2016
• The Enzyme Linked Immunosorbent Assay diagnostic technique segment is anticipated to witness high Y-o-Y rates of growth throughout the forecast period and is anticipated to reach a market valuation of US$ 390.9 Mn by the end of 2016. The Particle-Enhanced Turbidimetric Immunoassay diagnostic technique segment is estimated to register a CAGR of 7.0% over the forecast period
• The Diagnostic Labs end user segment is anticipated to reach a market value share of US$ 308.4 Mn by the end of 2016. The Outpatient Clinics end user segment is estimated to hold a market value share of 30.1% by the end of 2016, making it the second highest end user growth segment of the global renal biomarker market

Regional analysis

The global renal biomarker market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). The North America renal biomarker market is projected to witness high Yea-on-Year growth throughout the forecast period. The market in this region is anticipated to witness a CAGR of 7.6% over the forecast period. The presence of leading renal biomarker manufacturers and established distribution channels in North America is expected to create significant growth opportunities over the next 10 years. The Western Europe renal biomarker market is estimated to represent absolute $ opportunity of US$ 14.1 Mn in 2017 over 2016.

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-1731

Vendor insights

The global renal biomarker market report profiles a few of the top companies dominating the global market. Leading market players featured in the report include Thermo Fisher Scientific Inc., BIOPORTO A/S, Abbott Laboratories, Astute Medical, Inc., Randox Laboratories Ltd. and Beckman Coulter, Inc. (Danaher Corporation). The report discusses individual strategies adopted by these companies in terms of enhancing product designing, creating new manufacturing facilities, market consolidation, and advanced R&D initiatives.

Market segmentation

By Biomarker Type:

• Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin
• Up-Regulated Proteins
  • Neutrophil gelatinase-associated lipocalin
  • Kidney injury molecule 1
  • Interleukin 18
• Others

By Diagnostic Technique:

• Enzyme Linked Immunosorbent Assay
• Particle-Enhanced Turbidimetric Immunoassay
• Colorimetric Assay
• Chemiluminescent Enzyme Immunoassay
• Liquid Chromatography-Mass Spectrometry

By End User:

• Diagnostic Labs
• Outpatient Clinics
• Research Centres
• Hospitals

Request for Customization: https://www.futuremarketinsights.com/customization-available/REP-GB-1731

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe

Asia Pacific Excluding Japan (APEJ)

• Japan
• Middle East & Africa (MEA)

Read Related Reports:

https://www.zedlike.com/blogs/19911/Airway-Management-Devices-Market-Top-Trends-and-industry-overview-to

https://gezelligkletsen.nl/read-blog/12361

https://ai.wiki/read-blog/31365

https://jejaring.lokadaya.id/read-blog/2968

https://komunikado.mx/read-blog/3227

http://www.renexus.org/network/read-blog/89163

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs